Long-Term Outcome by Risk Factors Using Conformal High Dose Rate Boost for Prostate Cancer

Reviewer: William Levin, MD
OncoLink
Ultima Vez Modificado: 8 de octubre del 2002

Translation for this article does not exist

Blogs

Healing Paws: Claire, Elise, Kim, Don and Finn
by OncoLink Editorial Team
February 09, 2016